Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
QTTB compared with PRLD: revenue, margins and what each company keeps, and the suppliers and customers both name
QTTB
Q32 Bio Inc.
Change
Mkt cap
Revenue
Revenue
PRLD
Prelude Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
QTTB
Q32 Bio Inc.
vs
PRLD
Prelude Therapeutics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only QTTB
6
BMY
Bristol-Myers Squibb Company ("BMS")
supplier
AKBA
Akebia Therapeutics, Inc. ("Akebia")
customer
—
The Regents of the University of Colorado ("Colorado")
unlisted
supplier
—
Horizon Therapeutics Ireland DAC
unlisted
supplier
2 more · QTTB chain
›
Shared
0
No shared counterparties.
Only PRLD
3
INCY
Incyte
customer
ABCL
AbCellera Biologics
customer
—
Pathos AI
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
QTTB
Q32 Bio Inc.
Change
8.68
· pre 8.70
· delayed
Mkt cap
$259.3M
Revenue
$54M
Q4 FY25
PRLD
Prelude Therapeutics Inc
Change
3.84
· pre 3.84
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$306.4M
Revenue
$6M
Q2 FY26
vs
Compare
Pre-market
Nov 3 '26
delayed
QTTB
Q32 Bio Inc.
vs
PRLD
Prelude Therapeutics Inc
8.68
pre 8.70
delayed
Price
3.84
pre 3.84
delayed
$259.3M
Mkt cap
$306.4M
Q4 FY25
$54M
Revenue
$6M
Q2 FY26
Change
Change
QTTB
8.68
vs
PRLD
3.84
Pre-market
Nov 3 '26
delayed